New Haven, CT – According to filings with the U.S. Securities and Exchange Commission, Cybrexa Therapeutics is raising $29,923,348.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, Per Hellsund played…
New Haven, CT – According to filings with the U.S. Securities and Exchange Commission, Artizan Biosciences is raising $10,877,922.00 in new funding. Sources indicate as part of senior management President, James Rosen played a key…
New Haven, CT — E. H. Kaufman Enterprises, Inc. dba Yale Surgical Company O&P has secured $1,600,000.00 in new commercial financing for expansion opportunities in New Haven. According to the company website, Since our company’s…